Cargando…
PSMG2-controlled proteasome-autophagy balance mediates the tolerance for MEK-targeted therapy in triple-negative breast cancer
Although the MAPK pathway is aberrantly activated in triple-negative breast cancers (TNBCs), the clinical outcome of MEK-targeted therapy is still poor. Through a genome-wide CRISPR-Cas9 library screening, we find that inhibition of PSMG2 sensitizes TNBC cells BT549 and MB468 to the MEK inhibitor AZ...
Autores principales: | Wang, Xueyan, Yu, Jing, Liu, Xiaowei, Luo, Dan, Li, Yanchu, Song, Linlin, Jiang, Xian, Yin, Xiaomeng, Wang, Yan, Chai, Li, Luo, Ting, Jing, Jing, Shi, Hubing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512673/ https://www.ncbi.nlm.nih.gov/pubmed/36099919 http://dx.doi.org/10.1016/j.xcrm.2022.100741 |
Ejemplares similares
-
Prognostic and Immune Infiltration Value of Proteasome Assembly Chaperone (PSMG) Family Genes in Lung Adenocarcinoma
por: Xuan, Do Thi Minh, et al.
Publicado: (2023) -
PSMG3‐AS1 enhances glioma resistance to temozolomide via stabilizing c‐Myc in the nucleus
por: Zhou, Li, et al.
Publicado: (2022) -
Genome-wide CRISPR-cas9 knockout screening identifies GRB7 as a driver for MEK inhibitor resistance in KRAS mutant colon cancer
por: Yu, Chune, et al.
Publicado: (2021) -
miR-143-3p Targets lncRNA PSMG3-AS1 to Inhibit the Proliferation of Hepatocellular Carcinoma Cells
por: Zhang, Jianlin, et al.
Publicado: (2020) -
miR-4417 targets lncRNA PSMG3-AS1 to suppress cell invasion and migration in cervical squamous cell carcinoma
por: Man, Shuhong, et al.
Publicado: (2021)